EMA — authorised 23 November 2015
- Marketing authorisation holder: Amgen Europe B.V.
- Status: approved
🇪🇺 Blincyto in European Union
EMA authorised Blincyto on 23 November 2015
Marketing authorisation
Blincyto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Blincyto approved in European Union?
Yes. EMA authorised it on 23 November 2015.
Who is the marketing authorisation holder for Blincyto in European Union?
Amgen Europe B.V. holds the EU marketing authorisation.